Kiniksa Pharmaceuticals International, plc (KNSA)

NASDAQ: KNSA · Real-Time Price · USD

74.61

-1.12 (-1.48%)

At close: Sep 30, 2026, 4:00 PM EDT

75.35

+0.74 (0.99%)

Pre-market: Oct 1, 2026, 4:00 AM EDT

KNSA Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	840.85	677.56	423.24	270.26	220.18	38.54
Revenue Growth	58.85%	60.09%	56.61%	22.75%	471.24%	-
Cost of Revenue	382.55	307.22	189.22	89.93	46.97	9.94
Gross Profit	458.3	370.35	234.02	180.33	173.21	28.61
Selling, General & Admin	230.9	196.27	168.01	129.43	97.95	85.95
Research & Development	127.15	96.85	111.62	76.1	65.49	99.3
Operating Expenses	358.05	293.13	279.63	205.52	163.44	185.25
Operating Income	100.25	77.22	-45.62	-25.2	9.77	-156.64
Other Non Operating Income (Expenses)	14	11.65	9.46	8.54	1.25	0.1
Pretax Income	114.25	88.87	-36.15	-16.65	11.03	-156.54
Income Tax Expense	33.59	29.86	7.04	-30.74	-172.34	1.39
Net Income	80.66	59.01	-43.19	14.08	183.36	-157.92
Net Income to Common	80.66	59.01	-43.19	14.08	183.36	-157.92
Net Income Growth	1583.88%	-	-	-92.32%	-	-
Shares Outstanding (Basic)	76	74	71	70	69	69
Shares Outstanding (Diluted)	82	79	71	72	70	69
Shares Change	9.97%	10.58%	-0.69%	2.13%	2.69%	10.89%
EPS (Basic)	1.06	0.80	-0.60	0.20	2.64	-2.30
EPS (Diluted)	0.99	0.75	-0.60	0.20	2.60	-2.30
EPS Growth	1399.63%	-	-	-92.31%	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	182.84	136.42	25.41	13.17	5.7	-126.71
Free Cash Flow Per Share	2.23	1.73	0.36	0.18	0.08	-1.85
Gross Margin	54.50%	54.66%	55.29%	66.72%	78.67%	74.22%
Operating Margin	11.92%	11.40%	-10.78%	-9.32%	4.44%	-406.38%
Profit Margin	9.59%	8.71%	-10.21%	5.21%	83.28%	-409.72%
Free Cash Flow Margin	21.74%	20.13%	6.00%	4.87%	2.59%	-328.75%
EBITDA	102.04	78.78	-43.92	-22.86	12.18	-154.28
EBITDA Margin	12.13%	11.63%	-10.38%	-8.46%	5.53%	-
D&A For EBITDA	1.79	1.55	1.7	2.34	2.4	2.36
EBIT	100.25	77.22	-45.62	-25.2	9.77	-156.64
EBIT Margin	11.92%	11.40%	-10.78%	-9.32%	4.44%	-
Effective Tax Rate	29.40%	33.60%	-	-	-	-
Revenue as Reported	840.85	677.56	423.24	270.26	220.18	38.54
Advertising Expenses	-	12.06	11.43	9.07	5.73	-

SEC Filings: 10-K · 10-Q